Prehabilitation for Adults With End Stage Renal Disease on the Kidney Transplant Waitlist
1 other identifier
interventional
18
1 country
1
Brief Summary
This pilot study will be a clinical trial to test the feasibility and effectiveness of a kidney transplant (KT) prehabilitation intervention in adults with end stage renal disease (ESRD) who are within 3-6 months of transplantation.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started May 2016
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 27, 2016
CompletedFirst Submitted
Initial submission to the registry
September 6, 2016
CompletedFirst Posted
Study publicly available on registry
September 9, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2018
CompletedFebruary 12, 2020
February 1, 2020
1.8 years
September 6, 2016
February 11, 2020
Conditions
Outcome Measures
Primary Outcomes (1)
Post kidney transplant mortality
1 year patient survival
1 year
Study Arms (1)
Prehabilitation
EXPERIMENTALInterventions
The study will use a generic prehabilitation program which will include the following components: Warm-up, cardiovascular training, strength training, flexibility training, and cool down. Prehabilitation will occur once per week and approximately 1 hour in duration. Participants will take part in prehabilitation until they receive a kidney transplant which by study design is approximately for 3-6 months.
Eligibility Criteria
You may qualify if:
- Men and women with end stage renal disease who are within 3-6 months of kidney transplantation and are on the kidney transplant waitlist at Johns Hopkins
- Must be at least 18 years or older at enrollment
- Must be English speaking
- Must be enrolled in an ongoing cohort study of adults with ESRD who are being evaluated for kidney transplantation
- Must be willing to participate in a prehabilitation program and able to give informed consent
You may not qualify if:
- Patients who have any of the following medical conditions will be excluded from the study:
- Active Angina pectoris
- Chronic lung disease and daily use of oxygen
- Cerebral vascular disease
- Musculoskeletal conditions that would limit participation in prehabilitation
- Lower- or upper-extremity amputation
- Orthopedic disorders exacerbated by physical activity
- Decreased mental capacity
- Patients who live outside of Maryland will not be included in the study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Johns Hopkins Physical Medicine and Rehabilitation
Lutherville, Maryland, 21093, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Mara McAdams DeMarco, PhD
Johns Hopkins Bloomberg School of Public Health
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 6, 2016
First Posted
September 9, 2016
Study Start
May 27, 2016
Primary Completion
April 1, 2018
Study Completion
April 1, 2018
Last Updated
February 12, 2020
Record last verified: 2020-02
Data Sharing
- IPD Sharing
- Will not share